These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 20979454)

  • 61. Seroprotective antibodies to 2011 variant influenza A(H3N2v) and seasonal influenza A(H3N2) among three age groups of US Department of Defense service members.
    Radin JM; Hawksworth AW; Ortiguerra RG; Brice GT
    PLoS One; 2015; 10(3):e0121037. PubMed ID: 25816244
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients.
    Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
    Transpl Infect Dis; 2015 Jun; 17(3):371-9. PubMed ID: 25817044
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Universal influenza vaccines, science fiction or soon reality?
    de Vries RD; Altenburg AF; Rimmelzwaan GF
    Expert Rev Vaccines; 2015; 14(10):1299-301. PubMed ID: 26104835
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months.
    Lee JH; Cho HK; Kim KH; Lee J; Kim YJ; Eun BW; Kim NH; Kim DH; Jo DS; Kim HM; Kim YK
    J Korean Med Sci; 2019 Dec; 34(46):e279. PubMed ID: 31779056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Trivalent inactivated influenza vaccine in African adults infected with human immunodeficient virus: double blind, randomized clinical trial of efficacy, immunogenicity, and safety.
    Madhi SA; Maskew M; Koen A; Kuwanda L; Besselaar TG; Naidoo D; Cohen C; Valette M; Cutland CL; Sanne I
    Clin Infect Dis; 2011 Jan; 52(1):128-37. PubMed ID: 21148531
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contemporary seasonal influenza A (H1N1) virus infection primes for a more robust response to split inactivated pandemic influenza A (H1N1) Virus vaccination in ferrets.
    Ellebedy AH; Fabrizio TP; Kayali G; Oguin TH; Brown SA; Rehg J; Thomas PG; Webby RJ
    Clin Vaccine Immunol; 2010 Dec; 17(12):1998-2006. PubMed ID: 20962210
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Local antibody immune responses in influenza patients and persons vaccinated with seasonal, pre-pandemic, and pandemic live attenuated influenza vaccines].
    Donina SA; Petukhova GD; Koren'kov DA; Grigor'eva EP; Kuznetsova SA; Losev IV; Rudenko LG; Naĭkhin AN
    Vopr Virusol; 2013; 58(3):37-42. PubMed ID: 24006632
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.
    Nayak JL; Fitzgerald TF; Richards KA; Yang H; Treanor JJ; Sant AJ
    J Infect Dis; 2013 Jan; 207(2):297-305. PubMed ID: 23148285
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Seroprevalence of pandemic (H1N1) 2009 influenza and effectiveness of 2010/2011 influenza vaccine during 2010/2011 season in Beijing, China.
    Yang P; Zhang L; Shi W; Lu G; Cui S; Peng X; Zhang D; Liu Y; Liang H; Pang X; Wang Q
    Influenza Other Respir Viruses; 2012 Nov; 6(6):381-8. PubMed ID: 22212858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model.
    Tan J; O'Dell G; Hernandez MM; Sordillo EM; Kahn Z; Kriti D; van Bakel H; Ellebedy AH; Wilson PC; Simon V; Krammer F; McMahon M
    J Virol; 2022 Jan; 96(2):e0142121. PubMed ID: 34669506
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hemagglutinin stem reactive antibody response in individuals immunized with a seasonal influenza trivalent vaccine.
    Zhao X; Qin K; Guo J; Wang D; Li Z; Zhu W; Liu L; Wang D; Shu Y; Zhou J
    Protein Cell; 2015 Jun; 6(6):453-457. PubMed ID: 25940943
    [No Abstract]   [Full Text] [Related]  

  • 72. Quadrivalent Influenza Vaccine-Induced Antibody Response and Influencing Determinants in Patients ≥ 55 Years of Age in the 2018/2019 Season.
    Ganczak M; Dubiel P; Drozd-Dąbrowska M; Hallmann-Szelińska E; Szymański K; Brydak LB
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31739554
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influenza vaccine immunology.
    Dormitzer PR; Galli G; Castellino F; Golding H; Khurana S; Del Giudice G; Rappuoli R
    Immunol Rev; 2011 Jan; 239(1):167-77. PubMed ID: 21198671
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people.
    Frobert E; Bouscambert-Duchamp M; Escuret V; Mundweiler S; Barthélémy M; Morfin F; Valette M; Gerdil C; Lina B; Ferraris O
    Curr Microbiol; 2010 Jul; 61(1):25-8. PubMed ID: 20033691
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vaccination against influenza in patients with systemic sclerosis.
    Litinsky I; Balbir A; Zisman D; Mandelboim M; Mendelson E; Feld J; Braun Y; Anouk M; Kaufman I; Paran D; Caspi D; Elkayam O
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.
    He XS; Holmes TH; Sanyal M; Albrecht RA; García-Sastre A; Dekker CL; Davis MM; Greenberg HB
    J Infect Dis; 2015 Apr; 211(7):1051-9. PubMed ID: 25336731
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Vaccination strategies to protect children against seasonal and pandemic influenza.
    Rimmelzwaan GF; Bodewes R; Osterhaus AD
    Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase IV: randomized controlled trial to evaluate lot consistency of trivalent split influenza vaccines in healthy adults.
    Song JY; Cheong HJ; Lee J; Wie SH; Park KH; Kee SY; Jeong HW; Kim YS; Noh JY; Choi WS; Park DW; Sohn JW; Kim WJ
    Hum Vaccin Immunother; 2014; 10(10):2958-64. PubMed ID: 25483462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.